Related references
Note: Only part of the references are listed.Structural basis of Von Willebrand Factor multimerization and tubular storage
Jianwei Zeng et al.
BLOOD (2022)
The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells
Jeremy Lagrange et al.
CARDIOVASCULAR RESEARCH (2022)
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis
Yi He et al.
FRONTIERS IN ONCOLOGY (2021)
Hypoxia Induces Overexpression of CCL28 to Recruit Treg Cells to Enhance Angiogenesis in Lung Adenocarcinoma
Bingchun Liu et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2021)
Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta-analysis
Xun Peng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients
Ying Ding et al.
THORACIC CANCER (2020)
Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis
Mengge Fan et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Bioinformatics analysis of differentially expressed genes in tumor and paracancerous tissues of patients with lung adenocarcinoma
Rong Yang et al.
JOURNAL OF THORACIC DISEASE (2020)
The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing
Jun Ishihara et al.
BLOOD (2019)
Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis
Melissande Cossutta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Erg mediates downregulation of claudin-5 in the brain endothelium of a murine experimental model of cerebral malaria
Fuhong Liu et al.
FEBS LETTERS (2019)
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study
Hanna L. Obermeier et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
A biophysical view on von Willebrand factor activation
Achim Loef et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer
Renyong Guo et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Emerging Roles for von Willebrand Factor in Cancer Cell Biology
Jamie M. O'Sullivan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
von Willebrand factor regulation of blood vessel formation
Anna M. Randi et al.
BLOOD (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors
Robert E. Hynds et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma
Andrea Pace et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells
Xia Wang et al.
TOXICOLOGY LETTERS (2018)
Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
Yingxue Qi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer Patients
Razelle Kurzrock et al.
CLINICAL CANCER RESEARCH (2017)
Synthesis of Novel c(AmpRGD) Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis
Andrea Sartori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
VEGF as a potential target in lung cancer
Daniela Frezzetti et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Thrombotic Microangiopathies (TTP, HUS, HELLP)
Shane Kappler et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
von Willebrand factor and inflammation
C. Kawecki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Von Willebrand factor and angiogenesis: basic and applied issues
A. M. Randi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Effects of the tumor microenvironment
Laura M. Zahn
SCIENCE (2017)
Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis
Xia Wang et al.
ONCOTARGET (2017)
GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature
Yinghua Xu et al.
ONCOTARGET (2017)
Thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges
Kodappully Sivaraman Siveen et al.
CURRENT VASCULAR PHARMACOLOGY (2017)
Pathophysiology of thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2017)
The impact of von Willebrand factor on factor VIII memory immune responses
Juan Chen et al.
BLOOD ADVANCES (2017)
ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery
Haochen Xu et al.
BLOOD (2017)
von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells
Mafalda Lopes da Silva et al.
BLOOD (2016)
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer
M. Pepin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma
Giovanni Marfia et al.
CANCER MEDICINE (2016)
Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation
Alexander Scholz et al.
ANNALS REPORTS, VOL 1347 (2015)
Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice
Ju Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans
Alexander T. Bauer et al.
BLOOD (2015)
Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease
Joan C. Gill et al.
BLOOD (2015)
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends
Peter J. Lenting et al.
BLOOD (2015)
Lung cancer and metastasis: new opportunities and challenges
Xiangdong Wang et al.
CANCER AND METASTASIS REVIEWS (2015)
Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction
Yan Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Low-Dose Cadmium Upregulates VEGF Expression in Lung Adenocarcinoma Cells
Fuhong Liu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2015)
Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
Marcus Stockschlaeder et al.
BLOOD COAGULATION & FIBRINOLYSIS (2014)
Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor
Nathalie Saint-Lu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Sequence and structure relationships within von Willebrand factorSequence and structure relationships within von Willebrand factor
Yan-Feng Zhou et al.
BLOOD (2012)
ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score
Hiroaki Takaya et al.
HEPATOLOGY RESEARCH (2012)
Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle
Ju Liu et al.
BLOOD (2011)
Endothelial von Willebrand factor regulates angiogenesis
Richard D. Starke et al.
BLOOD (2011)
RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG
Lei Yuan et al.
BLOOD (2011)
Repressors NFI and NFY Participate in Organ-Specific Regulation of von Willebrand Factor Promoter Activity in Transgenic Mice
Marjan Nassiri et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Cooperation between integrin alpha(nu)beta(3) and VEGFR2 in angiogenesis
Payaningal R. Somanath et al.
ANGIOGENESIS (2009)
Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells
Kazuhiro Tamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Pharmacological Inhibition of Integrin αvβ3 Aggravates Experimental Liver Fibrosis and Suppresses Hepatic Angiogenesis
Eleonora Patsenker et al.
HEPATOLOGY (2009)
A+220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice
J. Liu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure
Ralf A. Claus et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice
Ann M. Kleinschmidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies
M. Van den Biggelaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex
William A. Barton et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Angiogenesis and phenotypic alteration of alveolar capillary endothelium in areas of neoplastic cell spread in primary lung adenocarcinoma
EJ Jin et al.
PATHOLOGY INTERNATIONAL (2001)
A single nucleotide polymorphism at nucleotide-1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels
PJ Harvey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
